ArticleRespiration; international review of thoracic diseases2026
Severe Asthma in Women: Clinical Characteristics and Pharmacological Implications for Tailored Management.
Article in Respiration; international review of thoracic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSex-specific differences in severe asthma - particularly those affecting women - remain underexplored, despite their potential impact on disease management and outcomes. A better understanding of these differences is key to advancing personalized and equitable care. Multiple population-based cohorts have reported a higher prevalence of asthma in adult women than in men, underscoring the clinical relevance of sex-based differences. The objective is to describe and compare sex-based clinical and pharmacological profiles among patients with severe asthma managed at a Severe Asthma Clinic (SAC) in a tertiary hospital in Spain.
methodsThis retrospective cohort study included adult patients with severe asthma followed at the SAC in 2024. Clinical variables (comorbidities, pulmonary function, biomarkers, and asthma control) and pharmacological variables (inhaled therapy prescriptions and adherence, rescue overuse, oral corticosteroid use, biologics, and comorbidity-related treatments) were analyzed using electronic health and pharmacy records.
resultsA total of 223 patients were included (157 women and 66 men). Women showed significantly poorer asthma control (Asthma Control Test 18.3 vs. 21.5, p < 0.05), lower fractional exhaled nitric oxide and IgE levels (p < 0.05), and higher rates of depression/anxiety (18.5% vs. 6.1%, p = 0.012). Pulmonary function tests revealed higher forced vital capacity (FVC) but lower forced expiratory volume in 1 s (FEV
conclusionWomen with severe asthma exhibit distinct clinical and pharmacological profiles that warrant sex-specific approaches to improve disease management and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.